Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients. (Q51842560)

13 April 2018

title

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients. (English)

1 reference

13 April 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

3

1 reference

13 April 2018

Johannes Jakowitsch

9

1 reference

13 April 2018

Gerald Maurer

10

1 reference

13 April 2018

Irene M Lang

11

object named as

Irene M Lang

1 reference

13 April 2018

author name string

Christopher Adlbrecht

1

1 reference

13 April 2018

Martin Hülsmann

2

1 reference

13 April 2018

Rudolf Berger

4

1 reference

13 April 2018

Deddo Mörtl

5

1 reference

13 April 2018

Joachim Struck

6

1 reference

13 April 2018

Nils G Morgenthaler

7

1 reference

13 April 2018

Andreas Bergmann

8

1 reference

13 April 2018

Richard Pacher

12

1 reference

13 April 2018

publication date

3 February 2009

1 reference

13 April 2018

European Journal of Heart Failure

published in

1 reference

13 April 2018

volume

11

1 reference

13 April 2018

issue

4

1 reference

13 April 2018

page(s)

361-366

1 reference

13 April 2018

Epidemiology, aetiology, and prognosis of heart failure

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Direct cardiac and vascular actions of adrenomedullin in conscious sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Atrial myocardium is the predominant inotropic target of adrenomedullin in the human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and tumour necrosis factor-alpha in patients referred for consideration of cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Hemodynamic and hormonal actions of adrenomedullin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Chronic Administration of Adrenomedullin Attenuates Transition From Left Ventricular Hypertrophy to Heart Failure in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

The role of endothelin receptor antagonists in the treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP004

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFP004

1 reference

13 April 2018

PubMed ID

19190023

1 reference

13 April 2018